|
|
Volumn 195, Issue , 2015, Pages 283-284
|
|
Pulsed levosimendan therapy in the management of chronic end stage cardiac failure in 'adult congenital heart disease'
|
|
Author keywords
Adult congenital heart disease; Cardiac failure; Therapeutics levosimendan
|
|
Indexed keywords
LEVOSIMENDAN;
CARDIOTONIC AGENT;
HYDRAZONE DERIVATIVE;
PYRIDAZINE DERIVATIVE;
SIMENDAN;
ADULT;
BRADYCARDIA;
CASE REPORT;
CHEST TIGHTNESS;
CONGENITAL HEART DISEASE;
DISEASE SEVERITY;
DRUG PULSE THERAPY;
DYSPNEA;
FATIGUE;
FEMALE;
HEART ATRIUM FLUTTER;
HEART DILATATION;
HEART FAILURE;
HUMAN;
LETTER;
MALE;
MIDDLE AGED;
PRIORITY JOURNAL;
PULMONARY HYPERTENSION;
PULMONARY VALVE ATRESIA;
ADVERSE EFFECTS;
COMPLICATION;
DISEASE COURSE;
HEART DEFECTS, CONGENITAL;
HEART SURGERY;
LIFE EXPECTANCY;
PATHOPHYSIOLOGY;
POSTOPERATIVE COMPLICATIONS;
PROCEDURES;
PSYCHOLOGY;
QUALITY OF LIFE;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
ADULT;
CARDIAC SURGICAL PROCEDURES;
CARDIOTONIC AGENTS;
DISEASE PROGRESSION;
FEMALE;
HEART DEFECTS, CONGENITAL;
HEART FAILURE;
HUMANS;
HYDRAZONES;
LIFE EXPECTANCY;
MALE;
MIDDLE AGED;
POSTOPERATIVE COMPLICATIONS;
PYRIDAZINES;
QUALITY OF LIFE;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
|
EID: 84937500794
PISSN: 01675273
EISSN: 18741754
Source Type: Journal
DOI: 10.1016/j.ijcard.2015.03.426 Document Type: Article |
|
Times cited : (2)
|
|
References (7)
|
